Epigenetic adaptation of beta cells across lifespan and disease.

Summary

Using cell-type-specific human methylomes, the authors show progressive age-related demethylation at regulatory elements of beta cell identity/function genes, with an opposite trend in alpha cells. In type 2 diabetes, beta cells exhibit further demethylation, suggesting an accelerated, ultimately failing compensatory epigenetic response to chronic insulin resistance.

Key Findings

• Progressive age-related demethylation at cis-regulatory elements of beta cell identity/function genes in healthy donors
• Alpha cells display a contrasting pattern with subtle age-related hypermethylation
• Type 2 diabetes beta cells show further demethylation, indicating an accelerated compensatory epigenetic response

Clinical Implications

Identifying beta-cell DNAm signatures across aging and T2D could inform risk stratification, track therapeutic responses, and guide development of epigenetic or metabolic interventions to preserve beta-cell function.

Limitations

• Cross-sectional design limits causal inference about the drivers of methylation changes
• Lack of interventional perturbation to directly link DNAm remodeling to beta-cell functional outcomes

Future Directions

Integrate longitudinal donor data, functional perturbations, and single-cell multi-omics to causally link specific epigenetic modifications to beta-cell survival and function under metabolic stress.